Avanir Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsAvanir Pharmaceuticals

Avanir Pharmaceuticals(AVNR)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Nuedexta	Dextromethorphan, Quinidine	2010-10-29	2023-2040	Atrial fibrillation , Atrial flutter , Cardiac arrhythmias , Cough , Neurobehavioral manifestations , Sinusitis , Asthma , Common cold , Allergic rhinitis perennial , Urticaria , Vasomotor rhinitis , Whooping cough , Bronchitis , Pharyngitis , Laryngitis , Postoperative complications , Pain , Vomiting , Nausea , Anaphylaxis , Allergic conjunctivitis , Motion sickness , Tobacco use disorder , Attention deficit disorder with hyperactivity , Depressive disorder

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

Quinidine gluconate

healthy volunteers/patients

,

drug interactions

,

respiratory syncytial virus infections

,

,

non-alcoholic fatty liver disease

,

,

,

,

,

major depressive disorder

,

depressive disorder

,

parkinson disease

,

,

,

migraine disorders

,

disease progression

,

treatment-resistant depressive disorder

,

,

autistic disorder

,

multiple sclerosis

,

,

,

impulse control disruptive and conduct disorders

,

,

psychomotor agitation

,

cardiac arrhythmias

,

amyotrophic lateral sclerosis

,

motor neuron disease

,

,

cardiovascular diseases

,

,

ventricular fibrillation

,

,

brugada syndrome

,

,

huntington disease

,

,

,

diabetic neuropathies

,

ischemic stroke

,

blood coagulation disorders

,

hemostatic disorders

,

renal insufficiency

,

,

myocardial infarction

,

,

,

ventricular tachycardia

,

sudden death cardiac

,

,

,

alzheimer disease

,

,

atrial fibrillation

,

pseudobulbar palsy

,

,

traumatic brain injuries

,

,

metabolic clearance rate

,

,

vascular dementia

,

,

lewy body disease

,

neurodegenerative diseases

,

hyperhomocysteinemia

,

vitamin b 12 deficiency

,

,

frontotemporal dementia

,

tdp-43 proteinopathies

,

primary progressive aphasia

,

pick disease of the brain

,

cognitive dysfunction

,

iron deficiencies

Quinidine polygalacturonate

healthy volunteers/patients

,

drug interactions

,

respiratory syncytial virus infections

,

,

non-alcoholic fatty liver disease

,

,

,

,

,

major depressive disorder

,

depressive disorder

,

parkinson disease

,

,

,

migraine disorders

,

disease progression

,

treatment-resistant depressive disorder

,

,

autistic disorder

,

multiple sclerosis

,

,

,

impulse control disruptive and conduct disorders

,

,

psychomotor agitation

,

cardiac arrhythmias

,

amyotrophic lateral sclerosis

,

motor neuron disease

,

,

cardiovascular diseases

,

,

ventricular fibrillation

,

,

brugada syndrome

,

,

huntington disease

,

,

,

diabetic neuropathies

,

ischemic stroke

,

blood coagulation disorders

,

hemostatic disorders

,

renal insufficiency

,

,

myocardial infarction

,

,

,

ventricular tachycardia

,

sudden death cardiac

,

,

,

alzheimer disease

,

,

atrial fibrillation

,

pseudobulbar palsy

,

,

traumatic brain injuries

,

,

metabolic clearance rate

,

,

vascular dementia

,

,

lewy body disease

,

neurodegenerative diseases

,

hyperhomocysteinemia

,

vitamin b 12 deficiency

,

,

frontotemporal dementia

,

tdp-43 proteinopathies

,

primary progressive aphasia

,

pick disease of the brain

,

cognitive dysfunction

,

iron deficiencies

healthy volunteers/patients

,

drug interactions

,

respiratory syncytial virus infections

,

,

non-alcoholic fatty liver disease

,

,

,

,

,

major depressive disorder

,

depressive disorder

,

parkinson disease

,

,

,

migraine disorders

,

disease progression

,

treatment-resistant depressive disorder

,

,

autistic disorder

,

multiple sclerosis

,

,

,

impulse control disruptive and conduct disorders

,

,

psychomotor agitation

,

cardiac arrhythmias

,

amyotrophic lateral sclerosis

,

motor neuron disease

,

,

cardiovascular diseases

,

,

ventricular fibrillation

,

,

brugada syndrome

,

,

huntington disease

,

,

,

diabetic neuropathies

,

ischemic stroke

,

blood coagulation disorders

,

hemostatic disorders

,

renal insufficiency

,

,

myocardial infarction

,

,

,

ventricular tachycardia

,

sudden death cardiac

,

,

,

alzheimer disease

,

,

atrial fibrillation

,

pseudobulbar palsy

,

,

traumatic brain injuries

,

,

metabolic clearance rate

,

,

vascular dementia

,

,

lewy body disease

,

neurodegenerative diseases

,

hyperhomocysteinemia

,

vitamin b 12 deficiency

,

,

frontotemporal dementia

,

tdp-43 proteinopathies

,

primary progressive aphasia

,

pick disease of the brain

,

cognitive dysfunction

,

iron deficiencies

lupus nephritis

,

systemic lupus erythematosus

,

,

,

,

,

,

,

diabetic neuropathies

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use